Get access to our best features
Get access to our best features
Published 2 years ago

UPDATED: Flagship startup brings out the budget ax, chops staff and clinical plans as share price flounders

Summary by Endpoints News
One of Flagship’s startups appears to be buckling under the pressure of a steadily falling stock price. The microbiome company Kaleido Biosciences confirmed a new report that it's laying off staff, but is holding back on details, with CEO Dan Menichella telling Endpoints News in a statement: We have taken

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)